Skip To Content

News & Events: SPACS

Posts

  • September 25 2024

    NYSE Cancels Proposal To Extend SPAC Merger Deadlines

    The New York Stock Exchange has pulled a proposal that would have provided special purpose acquisition companies with more time to complete mergers while remaining listed, several months after it sought regulatory approval for the extension.

    www.law360.com

  • September 23 2024

    SPACs Try For A Comeback

    As a group, special purpose acquisition companies have crashed and burned spectacularly. Some 860 SPACs raised money from investors in the frenzied years 2020–2021, according to corporate advisor Kroll.  Less than 100 survived.

    www.gfmag.com

  • September 05 2024

    Blackstone $16 bln AI deal borrows from SPAC boom

    How does a buyer avoid paying a huge multiple for a fast-growing company in a hot sector? A group led by Blackstone (BX.N), appears to have managed to do so with its agreed A$24 billion, ($16.1 billion) offer on Wednesday to purchase Australia-based AirTrunk, which operates data centres for artificial intelligence developers like Microsoft (MSFT.O)

    www.reuters.com

  • September 05 2024

    Biotech Firm Medera Set to Go Public in $623M SPAC Deal

    Medera Inc., a clinical-stage biopharmaceutical company developing treatments for cardiovascular diseases, has reached an agreement to go public on the Nasdaq through a merger with Keen Vision Acquisition Corp. (Nasdaq: KVAC).

    www.themiddlemarket.com

  • September 03 2024

    Scilex’s Semnur Pharmaceuticals to go public through $2.5B SPAC merger as it advances sciatica prospect

    Semnur Pharmaceuticals, which is working on a non-opioid prospect for sciatica, has agreed to merge with special purpose acquisition company Denali Capital Acquisition Corp. in a deal worth $2.5 billion.

    www.fiercepharma.com

  • September 03 2024

    Lutnick Leads Sponsors Boosting SPACs to Biggest Month Since 2022

    The blank-check market is heating up after the largest month for related initial public offerings since 2022, with a mix of new and experienced sponsors pricing new deals and a rush of additional debutants expected to come.

    www.bloomberg.com

  • September 03 2024

    Semnur Pharmaceuticals to go public via SPAC merger with Denali Capital in $2.5 bln deal

    Semnur Pharmaceuticals, a wholly owned subsidiary of Scilex Holding Company (SCLX.O), will go public via a merger with special purpose acquisition company Denali Capital Acquisition Corp in a $2.5 billion deal, the companies said on Tuesday.

    www.reuters.com

  • August 29 2024

    Melco chairman Lawrence Ho-backed SPAC raises US$150 million on Nasdaq

    Black Spade Capital, the family office of Macau casino operator Melco Resorts & Entertainment’s chairman Lawrence Ho Yau-lung, listed its second special purpose acquisition company (SPAC) on Nasdaq on Wednesday.

    www.finance.yahoo.com

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”